04.21.21

Johnson & Johnson Vision Receives FDA Clearance and CE Mark for Veritas Vision System

Source: Johnson & Johnson Vision

Johnson & Johnson Vision announced the FDA 510(k) clearance and CE mark of its next-generation phacoemulsification device, the Veritas Vision System. The phaco system features technologies that allow surgeons to guide through any lens density with less surge and more stability. The new system also provides advancements in ergonomics to further enhance usability during cataract surgery, according to Johnson & Johnson Vision.

“While the phacoemulsification technique has been used successfully for decades, ease of use continues to be the unmet need with cataract surgeons,” Rajesh K. Rajpal, MD, Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision, said in a company news release. “Every aspect of Johnson & Johnson Vision’s new Veritas System was designed to give surgeons an excellent user experience – optimizing features for safety and efficiency, with improvements in two main areas: fluidics and ergonomics.”

Johnson & Johnson said it will provide additional information on the Veritas this summer, and expects a full commercial launch later this year.

The FDA clearance and CE mark of the Veritas Vision System comes a month after the company announced FDA approval of the Tecnis Eyhance [1] and Tecnis Eyhance Toric II IOL [2]. Both innovations come as the company celebrates the anniversary of its Tecnis platform, the proprietary combination of materials and design on which the company’s IOLs are built.

References

[1] The TECNIS Simplicity® Delivery System is used to fold and assist in inserting the TECNIS® EYHANCE IOL which is indicated for the visual correction of aphakia in adult patients in whom a cataractous lens has been removed by extracapsular cataract extraction. The lens is intended to be placed in the capsular bag.

[2] The TECNIS Simplicity® Delivery System is used to fold and assist in inserting the TECNIS® EYHANCE TORIC II IOLs which are indicated for the visual correction of aphakia and pre-existing corneal astigmatism in adult patients with or without presbyopia in whom a cataractous lens has been removed by phacoemulsification and who desire reduction in residual refractive cylinder. The lens is intended to be placed in the capsular bag.

[3] Disclaimer: Sales of products subject to registration and regulatory approval. Products might not be available in all EMEA countries.

Related Content